418 related articles for article (PubMed ID: 37501128)
1. Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies.
Bowden SJ; Doulgeraki T; Bouras E; Markozannes G; Athanasiou A; Grout-Smith H; Kechagias KS; Ellis LB; Zuber V; Chadeau-Hyam M; Flanagan JM; Tsilidis KK; Kalliala I; Kyrgiou M
BMC Med; 2023 Jul; 21(1):274. PubMed ID: 37501128
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus.
Cox JT
Baillieres Clin Obstet Gynaecol; 1995 Mar; 9(1):1-37. PubMed ID: 7600720
[TBL] [Abstract][Full Text] [Related]
4. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
Kjær SK; Frederiksen K; Munk C; Iftner T
J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
6. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
7. Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions.
Feng T; Cheng B; Sun W; Yang Y
BMC Womens Health; 2023 Nov; 23(1):599. PubMed ID: 37957634
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.
Rodríguez AC; Schiffman M; Herrero R; Hildesheim A; Bratti C; Sherman ME; Solomon D; Guillén D; Alfaro M; Morales J; Hutchinson M; Katki H; Cheung L; Wacholder S; Burk RD
J Natl Cancer Inst; 2010 Mar; 102(5):315-24. PubMed ID: 20157096
[TBL] [Abstract][Full Text] [Related]
9. Burning wood in the kitchen increases the risk of cervical neoplasia in HPV-infected women in Honduras.
Velema JP; Ferrera A; Figueroa M; Bulnes R; Toro LA; de Barahona O; Claros JM; Melchers WJ
Int J Cancer; 2002 Feb; 97(4):536-41. PubMed ID: 11802219
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
11. Co-infection with trichomonas vaginalis increases the risk of cervical intraepithelial neoplasia grade 2-3 among HPV16 positive female: a large population-based study.
Yang M; Li L; Jiang C; Qin X; Zhou M; Mao X; Xing H
BMC Infect Dis; 2020 Sep; 20(1):642. PubMed ID: 32873233
[TBL] [Abstract][Full Text] [Related]
12. Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence.
Frega A; Stentella P; De Ioris A; Piazze JJ; Fambrini M; Marchionni M; Cosmi EV
Cancer Lett; 2003 Jul; 196(2):127-34. PubMed ID: 12860270
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation, treatment, and outcomes associated with vaginal intraepithelial neoplasia: A retrospective study of 118 patients.
Yu D; Qu P; Liu M
J Obstet Gynaecol Res; 2021 May; 47(5):1624-1630. PubMed ID: 33754436
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus and predictors of cervical intraepithelial neoplasia among young mothers in a prospective follow-up study.
Louvanto K; Syrjänen KJ; Rintala MA; Grénman SE; Syrjänen SM
Acta Obstet Gynecol Scand; 2011 Feb; 90(2):167-73. PubMed ID: 21241262
[TBL] [Abstract][Full Text] [Related]
15. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
Schlecht NF; Kulaga S; Robitaille J; Ferreira S; Santos M; Miyamura RA; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
JAMA; 2001 Dec; 286(24):3106-14. PubMed ID: 11754676
[TBL] [Abstract][Full Text] [Related]
16. Specific human papillomavirus types and other factors on the risk of cervical intraepithelial neoplasia: a case-control study in Korea.
Kim CJ; Lee YS; Kwack HS; Yoon WS; Park TC; Park JS
Int J Gynecol Cancer; 2010 Aug; 20(6):1067-73. PubMed ID: 20683419
[TBL] [Abstract][Full Text] [Related]
17. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
18. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.
Kelly H; Weiss HA; Benavente Y; de Sanjose S; Mayaud P;
Lancet HIV; 2018 Jan; 5(1):e45-e58. PubMed ID: 29107561
[TBL] [Abstract][Full Text] [Related]
19. Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.
Branca M; Costa S; Mariani L; Sesti F; Agarossi A; di Carlo A; Galati M; Benedetto A; Ciotti M; Giorgi C; Criscuolo A; Valieri M; Favalli C; Paba P; Santini D; Piccione E; Alderisio M; De Nuzzo M; di Bonito L; Syrjänen K
Eur J Gynaecol Oncol; 2004; 25(6):689-98. PubMed ID: 15597844
[TBL] [Abstract][Full Text] [Related]
20. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]